TY  - JOUR
AU  - Atia, Ohad
AU  - Pujol-Muncunill, Gemma
AU  - Navas-Lopez, Victor Manuel
AU  - Orlanski-Meyer, Esther
AU  - Ledder, Oren
AU  - Lev-Tzion, Raffi
AU  - Focht, Gili
AU  - Shteyer, Eyal
AU  - Stein, Ronen
AU  - Aloi, Marina
AU  - Russell, Richard K
AU  - Martin-de-Carpi, Javier
AU  - Turner, Dan
PY  - 2022
DO  - 10.1111/apt.17092
UR  - http://hdl.handle.net/10668/19914
T2  - Alimentary pharmacology & therapeutics
AB  - Patients enrolled in randomised controlled trials (RCTs) may differ from the target population due to restricted eligibility criteria. To compare treatment response to biologics in routine practice for children with inflammatory bowel diseases (IBD)...
LA  - en
PB  - Wiley-Blackwell Publishing
KW  - Biological Products
KW  - Child
KW  - Colitis, Ulcerative
KW  - Crohn Disease
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - Infliximab
KW  - Randomized Controlled Trials as Topic
TI  - Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix.
TY  - research article
VL  - 56
ER  -